These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 11108708)

  • 1. ODNBase--a web database for antisense oligonucleotide effectiveness studies. Oligodeoxynucleotides.
    Giddings MC; Matveeva OV; Atkins JF; Gesteland RF
    Bioinformatics; 2000 Sep; 16(9):843-4. PubMed ID: 11108708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enduring consequences of neonatal treatment with antisense oligodeoxynucleotides to estrogen receptor messenger ribonucleic acid on sexual differentiation of rat brain.
    McCarthy MM; Schlenker EH; Pfaff DW
    Endocrinology; 1993 Aug; 133(2):433-9. PubMed ID: 8344188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thermodynamic criteria for high hit rate antisense oligonucleotide design.
    Matveeva OV; Mathews DH; Tsodikov AD; Shabalina SA; Gesteland RF; Atkins JF; Freier SM
    Nucleic Acids Res; 2003 Sep; 31(17):4989-94. PubMed ID: 12930948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antisense oligonucleotide inhibition of tryptophan hydroxylase activity in mouse brain.
    McCarthy MM; Nielsen DA; Goldman D
    Regul Pept; 1995 Oct; 59(2):163-70. PubMed ID: 8584751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antisense oligonucleotide technology in the development of cancer therapeutics.
    Tseng BY; Brown KD
    Cancer Gene Ther; 1994 Mar; 1(1):65-71. PubMed ID: 7621240
    [No Abstract]   [Full Text] [Related]  

  • 6. Prediction of VEGF mRNA antisense oligodeoxynucleotides by RNA structure software and their effects on HL60 and K562 cells.
    Fei J; Zhang Y
    Cell Biol Int; 2005 Sep; 29(9):737-41. PubMed ID: 15985377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AOBase: a database for antisense oligonucleotides selection and design.
    Bo X; Lou S; Sun D; Yang J; Wang S
    Nucleic Acids Res; 2006 Jan; 34(Database issue):D664-7. PubMed ID: 16381954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bias in nucleotide composition of antisense oligonucleotides.
    Smetsers TF; Boezeman JB; Mensink EJ
    Antisense Nucleic Acid Drug Dev; 1996; 6(1):63-7. PubMed ID: 8783797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Target site search and effective inhibition of leukaemic cell growth by a covalently closed multiple anti-sense oligonucleotide to c-myb.
    Moon IJ; Lee Y; Kwak CS; Lee JH; Choi K; Schreiber AD; Park JG
    Biochem J; 2000 Mar; 346 Pt 2(Pt 2):295-303. PubMed ID: 10677346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rational design and rapid screening of antisense oligonucleotides for prokaryotic gene modulation.
    Shao Y; Wu Y; Chan CY; McDonough K; Ding Y
    Nucleic Acids Res; 2006; 34(19):5660-9. PubMed ID: 17038332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of hybridization between synthetic oligodeoxynucleotides and RNA in living cells.
    Politz JC; Taneja KL; Singer RH
    Nucleic Acids Res; 1995 Dec; 23(24):4946-53. PubMed ID: 8559650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The therapeutic potential of antisense oligonucleotides.
    Sharma HW; Narayanan R
    Bioessays; 1995 Dec; 17(12):1055-63. PubMed ID: 8634067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uptake and effects of antisense oligodeoxynucleotides specific for rat metallothionein -1 and -2 mRNA in H4 rat hepatoma cells in culture.
    Vasconcelos MH; Tam SC; Beattie JH; Hesketh JE
    Biochem Soc Trans; 1996 Aug; 24(3):408S. PubMed ID: 8878952
    [No Abstract]   [Full Text] [Related]  

  • 14. Oligonucleotides antisense to the interleukin 1 receptor mRNA block the effects of interleukin 1 in cultured murine and human fibroblasts and in mice.
    Burch RM; Mahan LC
    J Clin Invest; 1991 Oct; 88(4):1190-6. PubMed ID: 1833422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TargetFinder: a software for antisense oligonucleotide target site selection based on MAST and secondary structures of target mRNA.
    Bo X; Wang S
    Bioinformatics; 2005 Apr; 21(8):1401-2. PubMed ID: 15598838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infusion of antisense oligodeoxynucleotides to the oxytocin receptor in the ventromedial hypothalamus reduces estrogen-induced sexual receptivity and oxytocin receptor binding in the female rat.
    McCarthy MM; Kleopoulos SP; Mobbs CV; Pfaff DW
    Neuroendocrinology; 1994 May; 59(5):432-40. PubMed ID: 8022519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of target protein half-life on the effectiveness of antisense oligonucleotide analog-mediated biologic responses.
    Spiller DG; Giles RV; Broughton CM; Grzybowski J; Ruddell CJ; Tidd DM; Clark RE
    Antisense Nucleic Acid Drug Dev; 1998 Aug; 8(4):281-93. PubMed ID: 9743466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antisense inhibition of the renin-angiotensin system in brain and peripheral organs.
    Mohuczy D; Phillips MI
    Methods; 2000 Nov; 22(3):197-209. PubMed ID: 11071815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Facilitating oligonucleotide delivery: helping antisense deliver on its promise.
    Gewirtz AM; Stein CA; Glazer PM
    Proc Natl Acad Sci U S A; 1996 Apr; 93(8):3161-3. PubMed ID: 8622906
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effects of STAT3 antisense oligonucleotide on proliferation and apoptosis of non-small cell lung cancer cell line A549].
    Zhu BR; Cai JM; Tang GS; Li BL; Gao F; Cui JG; Liu HC
    Ai Zheng; 2007 Aug; 26(8):820-7. PubMed ID: 17697540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.